While Illumina has overcome many of the technical hurdles to presenting complex genomic data in a handheld device, the ability to interpret that data reliably is still lacking — particularly when it comes to whole-genome data. BioInform recently spoke to Scott Kahn, Illumina's chief information officer, to discuss the challenges the company faces in putting these tools into consumers' hands.